Fieldpoint Private Securities’s Integra LifeSciences IART Stock Holding History

Fieldpoint Private Securities’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$2K	Sell	40 -95	-70%	-$5.71K	﹤0.01%	1186
2022 Q1	$9K	Buy	135 +75	+125%	+$4.94K	﹤0.01%	1108
2021 Q4	$4K	Buy	60 +15	+33%	+$1.01K	﹤0.01%	1326
2021 Q3	$3K	Hold	45	–	–	﹤0.01%	1375
2021 Q2	$3K	Hold	45	–	–	﹤0.01%	1319
2021 Q1	$3K	Hold	45	–	–	﹤0.01%	1311
2020 Q4	$3K	Buy	+45	New	+$2.42K	﹤0.01%	1244

Other funds holding IART

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fieldpoint Private Securities's IART Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Integra LifeSciences (IART) stake by 70% in Q2 2022, selling an estimated $5.71K and leaving 40 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1186.

Fieldpoint Private Securities first reported a position in IART in Q4 2020 and has held it in 7 quarters since. The position peaked at $9K in Q1 2022. 284 funds tracked by Wall St. Rank hold IART as of Q2 2022.

Fieldpoint Private Securities held 40 shares of Integra LifeSciences worth $2K as of Q2 2022.
Fieldpoint Private Securities sold 95 Integra LifeSciences shares in Q2 2022, an estimated $5.71K.
Integra LifeSciences made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #1186 holding.
Fieldpoint Private Securities first reported a position in Integra LifeSciences in Q4 2020 and has held it in 7 quarters since.
Fieldpoint Private Securities's Integra LifeSciences position peaked at $9K in Q1 2022.
284 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.